BioSpace News Archive

Business

CORRECTING and REPLACING Hansoh Pharma Announces Strategic Collaboration and Licensing Agreement for Almonertinib

Partnership aims to accelerate global access to almonertinib as a treatment for individuals with non-small cell lung cancer

July 23, 2020
·
5 min read
Pharm Country

Allovate Therapeutics Extends Free Allerdent® ProgramAllerdent® Enables Patients to Maintain Allergy Immunotherapy During COVID-19 Pandemic

Allovate Therapeutics, a New York-based biotechnology company, announced today that it has extended its free Allerdent® program.

July 23, 2020
·
5 min read
Pharm Country

DNA changes that cause neuropsychiatric disorders should be included in genomic screening programs, researchers say

Geisinger researchers have concluded there is sufficient evidence to consider including DNA changes that cause neurodevelopmental and psychiatric disorders in genomic screening programs.

July 23, 2020
·
3 min read
Business

Editas Medicine to Host Conference Call Discussing Second Quarter 2020 Results and Corporate Update

Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Thursday, August 6, 2020, at 5:00 p.m. ET to discuss a corporate update and results for the second quarter of 2020.

July 23, 2020
·
1 min read
Business

Opiant Pharmaceuticals to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 6, 2020

Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its second quarter 2020 financial results after the financial markets close on Thursday August 6, 2020.

July 23, 2020
·
1 min read
Business

Adamas to Announce Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report 2020 second quarter financial results on Thursday, August 6, 2020, after market close.

July 23, 2020
·
1 min read
Business

OrthoPediatrics Corp. to Report Second Quarter 2020 Financial Results on August 5, 2020Conference Call to Discuss Results on August 6, 2020 at 8:00 a.m. ET

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its second quarter 2020 financial results on Wednesday, August 5, 2020, after the market closes.

July 23, 2020
·
1 min read
Business

Stereotaxis to Report Second Quarter 2020 Financial Results on August 6, 2020

Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2020 second quarter on Thursday, August 6, 2020 before the open of the U.S. financial markets.

July 23, 2020
·
1 min read
Pharm Country

Adaptimmune Granted Access to PRIority MEdicines (PRIME) Regulatory Support by the European Medicines Agency for ADP-A2M4 for the Treatment of Synovial Sarcoma

Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, announced that the European Medicines Agency (EMA) has granted access to the PRIME initiative to the Company for ADP-A2M4 for the treatment of synovial sarcoma.

July 23, 2020
·
4 min read
Business

Cytokinetics to Announce Second Quarter Results on August 6, 2020

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report second quarter results on August 6, 2020 at 4:00 PM Eastern Time.

July 23, 2020
·
4 min read